Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Sofie Deschoemaeker"'
Autor:
Emile J. Clappaert, Daliya Kancheva, Jan Brughmans, Ayla Debraekeleer, Pauline M. R. Bardet, Yvon Elkrim, Dagmar Lacroix, Maida Živalj, Ahmed E.I. Hamouda, Jo A. Van Ginderachter, Sofie Deschoemaeker, Damya Laoui
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Conventional dendritic cells (cDCs) are at the forefront of activating the immune system to mount an anti-tumor immune response. Flt3L is a cytokine required for DC development that can increase DC abundance in the tumor when administered therapeutic
Externí odkaz:
https://doaj.org/article/ad19eef033c8482bbb80dc7e46ef2740
IFNγ signaling response in peripheral blood monocytes: A new prognostic biomarker for breast cancer?
Autor:
Sofie Deschoemaeker, Damya Laoui
Publikováno v:
EBioMedicine, Vol 53, Iss , Pp - (2020)
Externí odkaz:
https://doaj.org/article/1601982c54144f0183d58a7ee52d8edd
Autor:
Emma Verheye, Jesús Bravo Melgar, Sofie Deschoemaeker, Geert Raes, Anke Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Damya Laoui, Kim De Veirman
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 2, p 904 (2022)
Immunotherapeutic approaches, including adoptive cell therapy, revolutionized treatment in multiple myeloma (MM). As dendritic cells (DCs) are professional antigen-presenting cells and key initiators of tumor-specific immune responses, DC-based immun
Externí odkaz:
https://doaj.org/article/522d1345bcd543d2b3ec70bea9e6def2
Autor:
Giusy Di Conza, Sarah Trusso Cafarello, Stefan Loroch, Daniela Mennerich, Sofie Deschoemaeker, Mario Di Matteo, Manuel Ehling, Kris Gevaert, Hans Prenen, Rene Peiman Zahedi, Albert Sickmann, Thomas Kietzmann, Fabiola Moretti, Massimiliano Mazzone
Publikováno v:
Cell Reports, Vol 18, Iss 7, Pp 1699-1712 (2017)
Oxygen-dependent HIF1α hydroxylation and degradation are strictly controlled by PHD2. In hypoxia, HIF1α partly escapes degradation because of low oxygen availability. Here, we show that PHD2 is phosphorylated on serine 125 (S125) by the mechanistic
Externí odkaz:
https://doaj.org/article/dbfcf322e77844fe8764d55486a3635a
Autor:
Damya Laoui, Carola H. Ries, Martina Schmittnaegel, Greetje Vande Velde, Abhishek D. Garg, Sophie Janssens, Sofie Deschoemaeker, Niels Vandamme, Sabine Hoves, Louis Boon, Yvon Elkrim, Victor Bosteels, Ayla Debraekeleer, Ahmed E.I. Hamouda, Sana M. Arnouk, Jan Brughmans, Eva Hadadi, Jiri Keirsse, Isaure Vanmeerbeek, Daliya Kancheva, Helena Van Damme, Máté Kiss, Aleksandar Murgaski
Agonistic αCD40 therapy has been shown to inhibit cancer progression in only a fraction of patients. Understanding the cancer cell–intrinsic and microenvironmental determinants of αCD40 therapy response is therefore crucial to identify responsive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c8705c56f1955289a0b4fab89b0fdd1
https://doi.org/10.1158/0008-5472.c.6514056.v1
https://doi.org/10.1158/0008-5472.c.6514056.v1
Autor:
Damya Laoui, Carola H. Ries, Martina Schmittnaegel, Greetje Vande Velde, Abhishek D. Garg, Sophie Janssens, Sofie Deschoemaeker, Niels Vandamme, Sabine Hoves, Louis Boon, Yvon Elkrim, Victor Bosteels, Ayla Debraekeleer, Ahmed E.I. Hamouda, Sana M. Arnouk, Jan Brughmans, Eva Hadadi, Jiri Keirsse, Isaure Vanmeerbeek, Daliya Kancheva, Helena Van Damme, Máté Kiss, Aleksandar Murgaski
Supplementary Figure from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08db7c20b68f67424db03239cdfb9dc3
https://doi.org/10.1158/0008-5472.22432053
https://doi.org/10.1158/0008-5472.22432053
Autor:
Damya Laoui, Carola H. Ries, Martina Schmittnaegel, Greetje Vande Velde, Abhishek D. Garg, Sophie Janssens, Sofie Deschoemaeker, Niels Vandamme, Sabine Hoves, Louis Boon, Yvon Elkrim, Victor Bosteels, Ayla Debraekeleer, Ahmed E.I. Hamouda, Sana M. Arnouk, Jan Brughmans, Eva Hadadi, Jiri Keirsse, Isaure Vanmeerbeek, Daliya Kancheva, Helena Van Damme, Máté Kiss, Aleksandar Murgaski
Supplementary Data from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4aa4636b8a211b411daf06dad31b746
https://doi.org/10.1158/0008-5472.22432511.v1
https://doi.org/10.1158/0008-5472.22432511.v1
Autor:
Lena Claesson-Welsh, Massimiliano Mazzone, Wilhelm Jahnen-Dechent, Charlotte Rolny, Mathias Wenes, Sofie Deschoemaeker, Johan Botling, Marie Hedlund, Oriol Noguer, Christian König, Satoshi Honjo, Sònia Tugues
PDF file - 168K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d5a819e586257f8d7121bf7d914ca1e
https://doi.org/10.1158/0008-5472.22395416
https://doi.org/10.1158/0008-5472.22395416
Autor:
Morwena J. Solivio, Alessia Stornetta, Julie Gilissen, Peter W. Villalta, Sofie Deschoemaeker, Arne Heyerick, Ludwig Dubois, Silvia Balbo
Publikováno v:
Chemical Research in Toxicology, 35(2), 275-282. American Chemical Society
Many chemotherapeutic drugs exert their cytotoxicity through the formation of DNA modifications (adducts), which interfere with DNA replication, an overactive process in rapidly dividing cancer cells. Side effects from the therapy are common, however
Ovarian cancer (OC) is the deadliest gynecological malignancy in developed countries and is the seventh-highest cause of death in women diagnosed with cancer worldwide. Currently, several therapies are in use against OC, including debulking surgery,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::675bfdf962a7c9b3ad821b144a1b85b3
https://biblio.vub.ac.be/vubir/dendritic-cell-vaccines-a-promising-approach-in-the-fight-against-ovarian-cancer(d116a874-a82a-4092-9ffb-2a2838cc9092).html
https://biblio.vub.ac.be/vubir/dendritic-cell-vaccines-a-promising-approach-in-the-fight-against-ovarian-cancer(d116a874-a82a-4092-9ffb-2a2838cc9092).html